⌘K

Login Start Free

Home/Filings/4/0001933414-25-000149

4//SEC Filing

Gold Alexander M 4

Accession 0001933414-25-000149

CIK 0001933414other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 7:01 PM ET

Size

23.6 KB

Accession

0001933414-25-000149

Insider Transaction Report

Form 4

Period: 2025-11-11

Mineralys Therapeutics, Inc.MLYS

Gold Alexander M

Director

Transactions

Sale
Common Stock
2025-11-13$46.50/sh−12,742$592,503→ 0 total
Exercise/Conversion
Stock Option
2025-11-11−15,000→ 17,900 total
Exercise: $10.20Exp: 2035-02-13→ Common Stock (15,000 underlying)
Exercise/Conversion
Stock Option
2025-11-12−6,933→ 10,967 total
Exercise: $10.20Exp: 2035-02-13→ Common Stock (6,933 underlying)
Exercise/Conversion
Stock Option
2025-11-13−2,742→ 8,225 total
Exercise: $10.20Exp: 2035-02-13→ Common Stock (2,742 underlying)
Exercise/Conversion
Common Stock
2025-11-11$10.20/sh+15,000$153,000→ 15,000 total
Sale
Common Stock
2025-11-11$47.08/sh−5,000$235,408→ 0 total
Sale
Common Stock
2025-11-12$47.28/sh−1,933$91,386→ 0 total
Exercise/Conversion
Common Stock
2025-11-12$10.20/sh+6,933$70,717→ 6,933 total
Sale
Common Stock
2025-11-11$42.43/sh−10,000$424,298→ 5,000 total
Sale
Common Stock
2025-11-12$46.50/sh−5,000$232,500→ 1,933 total
Exercise/Conversion
Common Stock
2025-11-13$12.69/sh+10,000$126,900→ 12,742 total
Exercise/Conversion
Stock Option
2025-11-13−10,000→ 34,000 total
Exercise: $12.69Exp: 2034-06-13→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2025-11-13$10.20/sh+2,742$27,968→ 2,742 total

Footnotes (2)

[F1]The stock option vests in 12 monthly installments following the date of grant.
[F2]The stock option vests in 36 monthly installments beginning on July 13, 2024.

Documents

1 file

4
wk-form4_1763078474.xmlPrimary
FORM 4

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother

Related Parties

1

filerCIK 0002026429

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 7:01 PM ET
Size: 23.6 KB

View on SEC.gov